Paul Hartmann AG (PHH2) - Total Liabilities

Latest as of June 2025: €978.01 Million EUR ≈ $1.14 Billion USD

Based on the latest financial reports, Paul Hartmann AG (PHH2) has total liabilities worth €978.01 Million EUR (≈ $1.14 Billion USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Paul Hartmann AG (PHH2) cash flow conversion to assess how effectively this company generates cash.

Paul Hartmann AG - Total Liabilities Trend (2013–2024)

This chart illustrates how Paul Hartmann AG's total liabilities have evolved over time, based on quarterly financial data. Check PHH2 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Paul Hartmann AG Competitors by Total Liabilities

The table below lists competitors of Paul Hartmann AG ranked by their total liabilities.

Company Country Total Liabilities
China Shineway Pharmaceutical Group Limited
F:C1S
Germany €2.58 Billion
TOA Paint (Thailand) Public Company Limited
BK:TOA
Thailand ฿6.22 Billion
Mahindra Lifespace Developers Limited
NSE:MAHLIFE
India Rs48.12 Billion
First Financial Corporation Indiana
NASDAQ:THFF
USA $5.11 Billion
Hoang Anh Gia Lai JSC
VN:HAG
Vietnam ₫12.71 Trillion
Inox Green Energy Services Limited
NSE:INOXGREEN
India Rs4.38 Billion
Verusa Holding AS
IS:VERUS
Turkey TL1.18 Billion
WELL Health Technologies Corp
TO:WELL
Canada CA$1.17 Billion

Liability Composition Analysis (2013–2024)

This chart breaks down Paul Hartmann AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Paul Hartmann AG worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.07 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.87 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.45 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Paul Hartmann AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Paul Hartmann AG (2013–2024)

The table below shows the annual total liabilities of Paul Hartmann AG from 2013 to 2024.

Year Total Liabilities Change
2024-12-31 €901.80 Million
≈ $1.05 Billion
+3.51%
2023-12-31 €871.24 Million
≈ $1.02 Billion
-0.75%
2022-12-31 €877.81 Million
≈ $1.03 Billion
+19.91%
2021-12-31 €732.05 Million
≈ $855.85 Million
-3.32%
2020-12-31 €757.19 Million
≈ $885.23 Million
+11.85%
2019-12-31 €676.95 Million
≈ $791.43 Million
+17.49%
2018-12-31 €576.16 Million
≈ $673.59 Million
-0.17%
2017-12-31 €577.13 Million
≈ $674.73 Million
+12.47%
2016-12-31 €513.13 Million
≈ $599.90 Million
-1.23%
2015-12-31 €519.52 Million
≈ $607.37 Million
-6.70%
2014-12-31 €556.83 Million
≈ $650.99 Million
+3.17%
2013-12-31 €539.74 Million
≈ $631.01 Million
--

About Paul Hartmann AG

F:PHH2 Germany Medical Instruments & Supplies
Market Cap
$855.39 Million
€731.66 Million EUR
Market Cap Rank
#10252 Global
#1211 in Germany
Share Price
€206.00
Change (1 day)
+1.48%
52-Week Range
€203.00 - €257.00
All Time High
€376.24
About

Paul Hartmann AG manufactures and sells medical and care products in Germany, the rest of Europe, the Middle East, Africa, Asia and Pacific region, and the Americas. The company operates through three segments: Incontinence Management, Wound Care, and Infection Management. It offers absorbent underwear, incontinence pads and pants, and fixation pants; medical skincare products; wound management p… Read more